OpenAI acquires health-care technology startup Torch

OpenAI acquires health-care technology startup Torch


OpenAI has acquired the health-care technology startup Torch, the company announced on Monday.

Torch was building a “unified medical memory” for artificial intelligence that aimed to bring a patient’s health data, which is typically siloed and stored across a number of different vendors and formats, into one place.

Torch’s employees will join OpenAI as part of the deal, the companies said. OpenAI and Torch did not disclose the terms of the acquisition.

“I can’t imagine a better next chapter than to now get to put our technology and ideas in the hands of the hundreds of millions of people who already use ChatGPT for health questions every week,” Torch CEO Ilya Abyzov wrote in a post on X.

Abyzov previously co-founded another health-care startup called Forward, which was a direct-to-consumer primary care business that carried out patient visits via tech-enabled “CarePods.” Forward abruptly shuttered operations in 2024.

OpenAI’s acquisition of Torch comes just days after it unveiled ChatGPT Health, a new experience that allows users connect their medical records and wellness apps to the AI chatbot.

The company also announced several enterprise-grade products for health-care organizations. Some of its initial partners include large health systems like HCA Healthcare.

In December, OpenAI hired Google’s Albert Lee to lead corporate development, a signal that the company will continue to hunt for M&A targets that can help it gain an edge over rivals like Google and Anthropic.

The company made several acquisitions in 2025, including Jony Ive’s AI devices startup io for more than $6 billion in May.

WATCH: OpenAI, SoftBank invest $1 billion in SB Energy as part of Stargate

OpenAI, SoftBank invest $1 billion in SB Energy as part of Stargate



Source

Thanks for your support, here’s how to connect with us
Health

Thanks for your support, here’s how to connect with us

When Becky Quick announced the CNBC Cures initiative, our effort to raise awareness for rare diseases and improve the lives of the 30 million people living with them, we knew the response would be big. We didn’t know it would be this big. The response has been amazing, overwhelming and humbling. Thank you for your interest — […]

Read More
2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More